I think the directors should endorse it. The share price was languishing around low $4 mark after the last result and it has traded sideways for sometime. I do not own the stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025